REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
02/03/2025
Voltar para busca
Dado oficial do USPTO
HYBRIBODY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
HYBRIBODY
ST13
US500000079162192Classe
5, 42, 44
Pedido
79162192
Registro
4906690
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
44
Atualização mais recente
03/03/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42, 44
Data de depósito
25/11/2014
Data de registro
01/03/2016
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/03/2023
Última transação
03/03/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
708
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
FR
Examinador
DUBOIS, SUSAN
Unidade examinadora
M20
Titulares e representantes
Titulares
H. S. (pessoa física)
HYBRIGENICS SA
Representantes
Dmitriy O. Makarov IpHorgan Ltd.
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
[ Pharmaceutical preparations and veterinary products for the prevention and treatment of disorders of the immune system, the cardiovascular system, the metabolic system, genito-urinary system, the musculo-skeletal system, dermatologic system, alimentary tract, sensory organs, and parasitic diseases, for the treatment of inflammatory disorders for use in dermatology, oncology, hematology and in tissue and organ transplantation and for gastrointestinal disorders for humans or animals in needs thereof ]
Classe 42
[ Biochemical and pharmaceutical research and development for others of new experimental products for scientific purposes, pharmaceutical products and veterinary products for preventive or curative purposes of natural or artificial biological origin; ] scientific and engineering design services for the production and industrialization of experimental products for scientific purposes, pharmaceutical products and veterinary products; [ technical consulting on new development project studies, engineering design services; ] scientific laboratory services; [ quality management services, namely, quality evaluation and analysis, quality assurance, and quality control in the field of genomics, genetics, virology, human, animal or vegetable biology, bioinformatics, biotechnology, bacteriology, parasitology, zoology, botany, agronomy, plant and animal breeding, the agroindustry, the environment, health, pharmaceuticals, epidemiology, cosmetics, paleology and forensic science; ] technical consulting in the field of environmental and biological diagnosis, namely, chemical analysis [, analysis of water, energy audit energy saving; chemistry consultation services; surveying services; scientific research and technical consulting relating to carbon offsetting, chemical research, bacteriological research, biological research ]
Classe 44
[ Phytosanitary, veterinary or medical care services; therapeutic and sanitary diagnosis services, namely, for detection health risks, diagnosing illness or selecting treatment in humans and animals; biological diagnosis and medical diagnosis services ]
Publicações
Histórico de despachos e eventos da marca no USPTO.
44 publicações encontradas
RNWL
INTERNATIONAL REGISTRATION RENEWED
12/12/2024
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
18/12/2023
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
14/11/2023
INPC
INVALIDATION PROCESSED
14/11/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
03/11/2023
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
03/03/2023
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
03/03/2023
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
27/02/2023
PUM1
OFFICE ACTION ISSUED POU1
02/09/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/09/2022
ES75
TEAS SECTION 71 & 15 RECEIVED
23/08/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/05/2022
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/03/2021
CHLD
CHANGE OF OWNER RECEIVED FROM IB
19/10/2017
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
24/06/2016
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/06/2016
FIMP
FINAL DISPOSITION PROCESSED
02/06/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/06/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
01/03/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/12/2015
PUBO
PUBLISHED FOR OPPOSITION
15/12/2015
GPNX
NOTIFICATION PROCESSED BY IB
11/12/2015
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
25/11/2015
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
25/11/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/11/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/11/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/11/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/11/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/11/2015
ALIE
ASSIGNED TO LIE
27/10/2015
ALIE
ASSIGNED TO LIE
17/10/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/09/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/09/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/09/2015
RFNT
REFUSAL PROCESSED BY IB
17/04/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
31/03/2015
RFRR
REFUSAL PROCESSED BY MPU
31/03/2015
MAFR
APPLICATION FILING RECEIPT MAILED
31/03/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
28/03/2015
CNRT
NON-FINAL ACTION WRITTEN
27/03/2015
DOCK
ASSIGNED TO EXAMINER
27/03/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/03/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
26/03/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HYBRIBODY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.